Peripheral and Central Nervous System Drugs Advisory Committee
Committee Meeting on January 20, 2011, from 8 a.m. to 5 p.m.
Agenda: On January 20, 2011, the committee will discuss new drug application (NDA) 202-008,florbetapir F 18 injection, sponsored by Avid Radiopharmaceuticals, Inc., proposed for use in positron emission tomography (PET) imaging of [beta]-amyloid (beta-amyloid) aggregates in the brain to help rule out Alzheimer''s disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment